This study reports that Cyp3a41 gene contains 13 exons and is localized on the chromosome 5. CYP3A41 is a female-specific isoform that is predominantly expressed in the liver. Estrogen signaling is not responsible for its female specificity. CYP3A41 expression in kidney and brain is observed only in 50% of mice examined. PXR mediates dexamethasone-dependent suppression of CYP3A41. In contrast to CYP3A11, CYP3A41 expression is not induced by pregnenolone-16a-carbonitrile (PCN) in wild-type mice, but is significantly suppressed by PCN in PXR À/À mice. Phenobarbital and TCPOBOP induce CYP3A11 expression only in the presence of CAR, but have no effect on CYP3A41 expression. Immunoblot and erythromycin demethylase activity analysis reveal robust CYP3A induction after PCN treatment, which is poorly correlated to CYP3A41. These findings suggest a differential role for CAR/PXR in regulating individual CYP3A isoforms by previously characterized CYP3A inducers.
INTRODUCTION
Cytochrome P450s (CYPs) are a family of heme thiolate proteins responsible for the oxidative metabolism of various steroids, bile acids, hormones, eicosanoids and a large number of clinically active drugs. 1 The phase I metabolism of more than 50% of therapeutic drugs is catalyzed mainly by the CYP3A subfamily. 2 CYP3As are known to exhibit sex-, tissue-and age-dependent expression patterns. [3] [4] [5] [6] To add to the complexity, CYP3As can be induced and suppressed by a wide variety of xenobiotics. 2 This makes CYP3A isoforms especially interesting because, apart from drug-drug interactions, interindividual variation in CYP3As may account for some of the differences in therapeutic outcome.
To date, six mouse CYP3A isoforms namely CYP3A11, CYP3A13, CYP3A16, CYP3A25, CYP3A41 and CYP3A44 have been identified. 4, [7] [8] [9] [10] [11] [12] CYP3A11 is the most studied isoform and is regulated by nuclear receptors pregnane X receptor (PXR) 13, 14 and constitutive androstane receptor (CAR). 15, 16 PXR, a novel orphan nuclear receptor, has been implicated in CYP3A subfamily induction in response to various xenobiotics. 17, 18 This is inferred from the fact that PXREs are commonly present in various promoter regions of mouse CYP3As and are activated by known CYP3A inducers. 19 Additionally, PXR null mice exhibit a total lack of CYP3A11 induction following pregnenolone-16a-carbonitrile (PCN) or dexamethasone (Dex) treatment. 14 Alternatively, recent evidence suggests the role of another important xenobiotic receptor, CAR, in activating CYP3A expression through PXR defined elements. 20, 21 PXR and CAR fall under the same nuclear subfamily NR1, and share RXR as their heterodimeric partner. 22 These observations along with several reports clearly indicate crosstalk between the two receptors. Such a reciprocal activation of each other's response elements could in turn imply a fail-safe protection against toxicants.
Recently, it has been shown that CYP3A41 is expressed in a female-specific pattern. 10 Sakuma et al 10 cloned CYP3A41 and showed that the highest levels of CYP3A41 expression were reached after sexual maturation. Such a sexual dimorphism is interesting, and understanding the regulation of these genes will be the first step taken to elucidate gender-dependent clinical responses. This led us to investigate the molecular basis of CYP3A41 expression. This study reports the characterization of the genomic structure of Cyp3a41 and identification of putative steroid and orphan nuclear receptor binding sites in its 5 0 flanking region. Using CAR and PXR null mice, we were able to study the role of these xenobiotic receptors in mediating Cyp3a41 gene regulation. In addition, we also examined the status of total CYP3A protein levels and activity in PXR null animals. Based on our results, we can define independent roles for PXR and CAR in regulating CYP3A41 expression.
RESULTS

Gene Structure Determination of Cyp3a41
We identified Cyp3a41 gene structure by fishing the genomic sequence out of the GenBank (htgs accession number AC11427), followed by determination of the intron-exon boundaries (Table 1) . Cyp3a41 gene is localized on mouse chromosome 5. The gene organization reveals that Cyp3a41 gene spans approximately 62.3 kb and contains 13 exons ranging from 53 to 552 bp exon size (Table 1 ). An interesting observation was the huge 41.29 kb intron. We searched the intron to see if this was a result of Cyp3a41 gene duplication event, but we did not find any evidence supportive of this notion. The 5 0 flanking region of Cyp3a41 was scanned to identify putative promoter elements using TRANSFAC. 23 This search engine revealed putative binding sites for RXR half sites, PXR site (ER 6), estrogen receptor, SP1, HNF, OCT1, GATA1, CAAT and a TATA box among other elements (Table 2) .
Tissue Distribution of CYP3A41 in Male/Female Mice CYP3A41 expression was analyzed using an RT-PCR assay, as described in the experimental procedures. The 705 bp amplified product was restriction digested using Ban I to check its specificity. Ban I digestion gave the expected sized The 5 0 flanking region was analyzed using TRANSFAC for potential transcription factor sites and enhancer elements. Capital letters depict the recognition sequence for the transcription factors, while the small case letters show the adjoining nucleotide sequence in the CYP3A41 gene.
CAR/PXR-mediated expression and regulation of Cyp3a41 and 11 S Anakk et al bands of 218 and 487 bp specific for CYP3A41 (Figure 1a) . Using this assay, we were able to detect CYP3A41 in the liver and extrahepatic tissues, namely kidney and brain ( Figure  1b) . We could not detect any levels of CYP3A41 in either the heart or lungs (data not shown). CYP3A41 shows a femalespecific expression (Figure 1b) . The tissue distribution of CYP3A41 seems to be liver4brainXkidney ( Figure 1b) ; however, the expression in the kidney and brain was only observed in 50% of the female mice (Figure 1c) . We also analyzed for CYP3A41 levels in male mice, but no expression was observed after any of the treatments in either wildtype or CAR/PXR knockout mice.
Ovariectomy and Estrogen Treatment
In order to determine if the female-specific expression of CYP3A41 was estrogen-mediated, we compared its expression in controls, ovariectomized and ovariectomized mice injected with exogenous estrogen (as described in experimental procedure). We observed no significant change in the levels of expression among these groups ( Figure 2 ).
Role of Nuclear Receptors CAR/PXR in Modulating CYP3A41 Expression Studies in PXR Null Animals PCN treatment PCN, a well-known inducer of most CYP3As, was administered to both wild-type and PXR null animals to examine Cyp3a41 gene regulation by this receptor. In wildtype mice, we did not find any effect of PCN on CYP3A41 expression. On the contrary, PCN was able to suppress CYP3A41 mRNA levels efficiently in PXR À/À mice ( Figure  3a) . Furthermore, we looked into the CYP3A11 expression pattern due to PCN and our observation of a brisk induction of CYP3A11 in wild-type mice was consistent with earlier reports. This induction was absent in PXR À/À animals, implicating PXR as a mediator of PCN induction of CYP3A11 (Figure 3a ).
Dex treatment
To investigate the role of PXR in Cyp3a41 gene regulation, wild-type and PXR À/À mice were treated with Dex. The data in Figure 3b clearly show that CYP3A41 is severely 
Studies in CAR null animals PB and TCPOBOP treatments
Wild-type and CAR knockouts were treated with PB or TCPOBOP, as described in experimental procedures. TCPO-BOP or PB treatment failed to induce CYP3A41 expression in wild-type and in CAR null mice (Figure 4a ). In comparison to CYP3A41, CYP3A11 was induced by both PB and TCPOBOP in a CAR-dependent fashion.
Effects of androstanol on TCPOBOP induction of CYP3A11 and CYP3A41
To further clarify the significance of CAR in dictating CYP3A11 and CYP3A41 mRNA levels, animals were administered androstanol, an inverse agonist to CAR before ligand treatment. TCPOBOP was unable to induce CYP3A41 expression either in vehicle or androstanol-treated animals ( Figure 4b ). Alternatively, CYP3A11 induction by TCPOBOP was modestly suppressed by androstanol pretreatment.
Western Blot Analysis in PXR Knockout Animals PCN was able to induce total CYP3A protein levels strongly in both male and female mice. This induction was primarily through PXR; nevertheless, a modest increase in CYP3A was noted only in male PXR null mice after PCN treatment. We were unable to detect CYP3A levels in control male animals. Since there are no mouse-specific CYP3A antibodies available commercially, different antibodies raised against human CYP3A4 and rat CYP3A1/2 are used routinely, all of which have differential capacity to detect mouse CYP3A levels. Schuetz et al, 24 using anti-CYP3A1 antibody, were able to detect CYP3A expression only in two out of four control male mice. Also, they showed that anti-CYP3A4 antibody does not crossreact with CYP3A11, a major CYP3A isoform. This might explain our inability to detect CYP3A protein band in male mice. Conversely, in female mice, the basal CYP3A levels relied on the presence of PXR ( Figure 5 ). Also, in female PXR À/À mice treated with PCN, we failed to detect any CYP3A protein level, suggesting CYP3A downregulation. This downregulation is consistent with the mRNA results obtained for CYP3A41. One more interesting point, which is demonstrated in Western blot analysis, is that total CYP3A levels were higher in females than in males. This observation is consistent with several reports published previously. 6, 24 Erythromycin N-Demethylase Activity We assayed for erythromycin N-demethylation, as described in Materials and methods section, and observed almost 10-fold higher activity in female than in male mice. Moreover, on PCN induction, we observed a 100-fold increase in the activity of male mice, while females displayed only an eightfold increase (Figure 6a ). The data in male PXR null mice revealed a slight increase in activity after treatment with PCN, whereas female PXR À/À animals exhibited almost 50% decrease in activity. Ketoconazole, a specific human CYP3A4 inhibitor, showed a dose-dependent decrease in erythromycin metabolism, with an IC 50 of 0.94 mM (Figure 6b ).
DISCUSSION
It has become much more apparent that understanding the mechanism by which compounds induce CYP3As is necessary in order to predict drug-drug interactions. 2 Nuclear receptors have been implicated in regulating CYP genes in response to xenobiotics. 22 The two known xenobiotic receptors involved in CYP3A regulation are PXR and CAR. 21 In the present study, we define the role of PXR and CAR in regulation of Cyp3a41 gene expression. Constitutive CYP3A41 mRNA expression was observed in the liver, brain, and kidney, while none was detected in the heart or lung. Such a high expression in brain suggests an important role for CYP3A41 in metabolizing neuroactive drugs and/or endogenous neurosteroids. The role of CYPs in phase I drug metabolism in the neural tissue has been recently confirmed with several important isoforms that have been cloned from the brain. 25, 26 Interestingly, in the brain and kidney, the expression of CYP3A41 was found to be variable such that only three out of six animals showed expression. The explanation of such events is unclear at present, since the animals used in our study are inbred strains. However, such variable expression of P450s among the closely bred animals has been noted earlier. 6, 24 Although CYP3A41 is a female-specific isoform, Figure 5 Immunoblot analysis of total CYP3A levels in wild-type and PXR À/À mice. Microsomes were prepared from livers pooled from three animals and protein amounts estimated using BCA assay. A measure of 50 lg of microsomes was loaded in each lane and Western blot analysis was performed, as described in Materials and methods. Lanes 1 and 2 represent control mice and lanes 3 and 4 represent PXR null mice with vehicle or PCN treatment, respectively. The semiquantitation of CYP3A protein levels was done using a Bio Rad image analyzer. we did not find it to be estrogen regulated. Previous studies have demonstrated the importance of the sexually dimorphic growth hormone (GH) secretion in dictating sexspecific expression of CYP genes. 27, 28 In male rats, GH is secreted in a pulsatile fashion, resulting in plasma GH peaks of amplitude 200 ng/ml every 3-4 h. 29 In contrast, the female rat GH-secretory pattern is characterized by continuous levels of GH in blood, at an average level of 40-60 ng/ ml. 30 The downstream signaling of GH is mediated through the family of proteins known as signal transducers and activators of transcription (STATs) namely stat5a and 5b. Using stat5a and 5b knockout mice, Waxman's group has clearly demonstrated the importance of stat5b in regulating male-specific expression, while both stat5a and 5b are important for maintaining constitutive female-specific expression. 31, 32 Both CYP3A41 and 44 mRNAs were shown to disappear following hypophysectomy in female mice. 33 Sakuma et al 33 showed that exogenous supply of estradiol benzoate and testosterone propionate could act as inductive and suppressive factors, respectively, for both CYP3A41 and CYP3A44 mRNA expression. The effects of both estradiol and testosterone on the mRNAs expression of CYP3A41 and 44 relied on the presence of GH in either sex. 33 Post hypophysectomy, continuous infusion of human GH, was able to rescue this loss in expression. In our study, we were unable to see any estradiol-mediated effects on CYP3A41 expression. One possibility for the variation observed in our results from Sakuma's group could be due to their prolonged 2-week regimen of estradiol benzoate, while we treated the mice for a week. Another reason could be the age of the animals used; our study utilized 8-week-old mice, while the mice used in their study were 4-6-week old. This becomes relevant since the peak levels of CYP3A41 expression are reached in about 7 weeks of age; so ovariectomizing the animals before 7 weeks raises a possibility that estradiol is very essential only till the peak expression level is achieved, after which its role might be reduced or negligible. Similar to our results, Yamada et al 6 have reported that estradiol benzoate cannot restore the loss of CYP3A41 expression in aromatase null mice. Instead, they suggested that imprinting could be involved in femalespecific expression of CYP3A41.
CAR and PXR are two essential nuclear receptors that regulate many CYP genes during xenobiotic stress. 20, 21 Although their sex-specific regulation, if any, is not absolutely established, few reports have demonstrated their response to female sex hormones. For instance, PXR is not affected by estradiol, but shows a progesterone-mediated 50-fold induction during pregnancy. 34 On the other hand, estradiol can activate CAR by increasing nuclear translocation in a dose-dependent manner in HepG2 cells. 35 Conversely, CAR can antagonize ER-mediated transcription activation by squelching coactivator p160 in HepG2 cells. 36 This suggests a feedback mechanism between CAR and ER. The mechanism of gender-specific expression of CYP3A genes remains equivocal at the moment; nonetheless, its consequences on endogenous or xenobiotic metabolism cannot be underestimated. Sex-dependent differences in drug metabolism have been reported in humans. 37, 38 In fact, current FDA guidelines emphasize the necessity to study variability in drug metabolism and disposition in women with respect to their physiology. Identification of genderspecific CYP isoforms in different species is, therefore, a first step in understanding gender-biased drug metabolism. 3 The genomic characterization of Cyp3a41 gene revealed an array of regulatory elements in the 5 0 flanking region including PXRE (ER6), HNF4, STAT5, CAAT and others. It has been recently reported that HNF4A knockout mice show lack of PXR gene expression, while hepatic conditional HNF4A deletion leads to reduced basal and inducible CYP3A expression. 39 This establishes a crucial role for HNF4A in regulating PXR and in turn CYP3As. The involvement of STAT 5a and 5b in mediating sexually dimorphic expression of CYP genes has also been shown. 31 The identification of STAT5-binding elements in the 5 0 flanking region reinforces the idea of sexual dimorphic expression of CYP3A41, but whether this plays a functional role in this case is yet to be examined. Another interesting observation is the presence of a 42 kb intron between exons 5 and 6. The significance of such a large intron in the middle of the gene remains unclear. Our search failed to identify a gene duplication event or the presence of some other gene in this large intron in the Cyp3a41 coding region. The presence of this intron, however, raises the possibility of alternative exon splicing. If it really is involved in splicing events, this could possibly explain the CYP3A41 variable expression observed in the kidney and brain.
To investigate whether PXR is necessary in CYP3A41 induction by xenobiotics, we examined CYP3A41 mRNA expression in PXR null mice after treatment with DEX and PCN. PCN is a prototype PXR ligand, whereas DEX serves the role of a common ligand for PXR and GR. 7 The results from this study suggest that Dex-mediated suppression of CYP3A41 expression occurs via PXR. These results and those following are summarized in Table 3 . This is an interesting finding since CYP3A11 is induced by DEX and the induction is dependent upon PXR. 13 On the other hand, CYP3A13 is induced by DEX in the absence of PXR. 7 Thus, individual CYP3A isoforms show differential response to DEX. Moreover, when PCN is used as a ligand, it does not affect CYP3A41 expression in wild-type animals; however, a significant downregulation of CYP3A41 expression is evident in PXR null mice. This implies that PCN might act as a ligand for some other receptor that, in the absence of PXR, is activated and suppresses CYP3A41 gene expression. This again emphasizes the point that individual CYP3A isoforms are uniquely regulated and there are few, if any, universal regulation norms.
Unlike CYP3A11, TCPOBOP and PB did not increase CYP3A41 mRNA levels in CAR þ / þ mice or in CAR À/À mice. To establish this result more clearly, we utilized androstanol, an inverse agonist of CAR. Based on the data from these experiments, we conclude that CAR has a minimal role in regulating CYP3A41 expression. This is in contrast to CYP3A11, where we can see a robust CAR-dependent regulation by both PB and TCPOBOP. Also, our study supports the notion that androstanol can partially antagonize TCPOBOP induction of CYP3A11.
In addition to mRNA levels, we also examined total CYP3A protein expression profile in PCN-treated mice. The data indicate higher CYP3A levels in females in comparison to male mice. While PXR is essential to maintain CYP3A levels in females, it in fact inhibits the basal expression levels of male mice. A similar pattern of CYP3A11 mRNA inhibition in male animals has been previously observed with PXR and CAR. 13, 40 The significance of PXR/CARdependent regulation of CYP3A mRNA basal levels is not well understood and needs further characterization.
Further, in PXR þ / þ mice, total CYP3A protein levels show a robust induction upon PCN treatment in both males and females. Another interesting finding is that PCN selectively induces CYP3A levels only in male PXR À/À mice, whereas levels drop precipitously in PXR À/À females. The suppression of CYP3A proteins observed in PXR À/À female animals is considerably higher in comparison to what is seen with CYP3A41 mRNA levels; therefore, we suspect that contribution of an another female specific isoform, CYP3A44, could be equally important in these effects. Erythromycin N-demethylation activity correlates well with CYP3A immunoblots. These results indicate that CYP3A41 could be a predominant CYP3A isoform in female mice, whereas CYP3A11 seems the predominant form in male mice. Our results show that PXR ligands significantly downregulate CYP3A41, while CAR ligands produce negligible effects (Table 3) .
In summary, our results suggest that CYP3A regulation might involve pathways other than the major known ones namely CAR and PXR. The expression pattern in PXR/CAR double knockouts will shed more light on alternate mechanisms governing xenobiotic induction of CYP3A enzymes. The availability of such model is foreseeable in the future and will be actively pursued.
MATERIALS AND METHODS
Chemicals
Estradiol benzoate, phenobarbital, pregnenolone-16a-carbonitrile (PCN) and dexamethasone were obtained from Sigma ) mice were treated with Dex (100 mg/kg) 7 or PCN (400 mg/kg) or vehicle to study the role of PXR on CYP3A41 expression. 13 Both the inducers were dissolved in corn oil and injected intraperitoneally once daily for 4 days. Wild-type CAR þ / þ and CAR À/À mice were treated with either PB (100 mg/kg) or TCPOBOP (3 mg/kg) or corn oil for 3 days by intraperitoneal injection. 16 CAR inverse agonist experiments were done in wild-type mice injected intraperitoneally with a single dose of androstanol (100 mg/ kg) followed by TCPOBOP (3 mg/kg). In order to evaluate the role of E2 on CYP3A41 expression, female mice were ovariectomized and were treated with either estrogen (500 mg/kg) or sesame oil s.c. for a week. 3 At the end of the experiments, all mice including controls were killed, tissues excised, immediately frozen in liquid nitrogen, and stored at À801C until analyzed.
RNA Isolation and CYP3A41 Semiquantitative RT-PCR
Frozen tissues were thawed on ice, and total RNA was isolated using a commercially available reagent (RNA STAT-60, Tel Test Inc., Friendswood, TX, USA), according to the manufacturer's instructions. All samples were DNAse treated using RQ1 DNAse (Promega). The quality of the isolated RNA was assessed by electrophoresis on 1% agarose gels, based on the integrity of 28S and 18S bands after ethidium bromide staining. To distinguish CYP3A41 from the other homologous CYP3A isoforms, we designed specific primers for RT-PCR of CYP3A41 RNA followed by BanI restriction enzyme digest, to make sure that the amplified sequence was unique. The sense primer used was 5' TTC TTC AGC TGA TGA TGA ACG 3 0 and antisense primer was 5 0 CAG CAG AAC TCC TTG AGG GAA AC 3 0 . To ensure that each PCR reaction was performed within the linear range of amplification, test reactions were performed at 20, 25, 30 and 35 cycles. The optimal RT-PCR conditions were 501C RT (30 min), 941C denaturing (2 min, followed by 30 s), 561C annealing (1 min) and 561C extension (1 min) for 25 cycles. For extra hepatic tissues, RT-PCR was carried up to 40 cycles. RT-PCR amplified the expected 705 bp fragment of CYP3A41. Densitometry was carried out using Molecular Imager FX (Bio-Rad) imaging software to semiquantitate the relative amounts of CYP3A41 between the treatment groups, with b-actin used as an internal standard.
CYP3A11 mRNA Expression by RT-PCR CYP3A11 gene was amplified using 5 0 -GAG GAT CAC ACA CAC AGT TGT-3 0 and 5 0 -TGT GAC AGC AAG GAG AGG CGT T-3 0 as forward and reverse primers, respectively. The amplifications were performed with 1 mg of total RNA using the superscript one-step RT-PCR kit (Invitrogen Life Technologies, Inc., Carlsbad, CA, USA). The RT-PCR conditions used in the study were 501C RT (30 min), 941C denaturing (2 min, followed by 30 s done for 15 cycles), 561C annealing (1 min) and 721C extension (1 min) for 15 cycles.
Preparation of Microsomes
Microsomes from liver were prepared as previously described. 41 . Tissues were homogenized (20 strokes) in 6 volumes of potassium phosphate buffer (pH 7.4) containing 20 mM KPi, 0.25 M sucrose, 1 mM EDTA and a cocktail of protease inhibitors (1 mM PMSF, 1 mg/ml leupeptin and 0.7 mg/ml pepstatin). The homogenate was then centrifuged at 8500 r.p.m. for 20 min and the supernatant fraction was collected. The supernatant fraction was further centrifuged at 100 000 g for 45 min. The pellet obtained was washed in fresh buffer, and centrifuged again at 100 000 g for 45 min. The washed pellets were resuspended in the homogenate buffer and stored at À801C until analysis.
CYP3A Immunoblotting
The total protein concentration in microsomes was determined by BCA assay with bovine serum albumin (BSA) as the standard. Samples were boiled in Laemmli buffer and resolved on 4-15% gradient Tris-glycine sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels. Proteins were transferred to nitrocellulose membranes using a semi-dry transfer apparatus. Membranes were blocked for 4 h with 5% dried nonfat milk in TTBS (0.05% Tween 20 in Tris-buffered saline), followed by an overnight incubation at 41C in 1 : 1000 dilution of polyclonal rabbit anti-human primary antibody raised against CYP3A4. Membranes were then washed and incubated at room temperature with HRP-conjugated goat anti-rabbit secondary antibody (1 : 1000 dilution) for 2 h. Immunoreactivity was detected using a HRP chemiluminescense system (Pierce Rockford, IL, USA).
Activity Assays
The N-demethylation assay for erythromycin was performed in a final volume of 2 ml with 100 mM potassium phosphate buffer (pH 7.7), containing an aliquot of 0.2 mg microsomal protein, and 1 mM erythromycin. The reaction was initiated by the addition of NADPH to a final concentration of 1 mM (Sigma chemicals, MO, USA) and incubated at 371C for 10 min and terminated by addition of 600 ml 17.5% perchloric acid. The flourimetric measurement of the formaldehyde product formation was carried out at 420 nm excitation and emission at 515 nm, as described previously. 42 Inhibition studies were performed by preincubating the microsomes with ketoconazole (0-20 mM) for 3 min at 371C.
Statistical Analysis
Data are presented as mean þ SE. Statistical significance for the effects of the nuclear receptor ligands on CYP3A41 and differences among CYP3A41 expression between different treatment groups were determined using a two-tailed unpaired student's t-test. Multiple groups after various treatments were compared using one-way analysis of variance (ANOVA). Differences were considered significant if Po0.05.
